Recurrent Pityriasis Versicolor
Conditions
Brief summary
Serum Samples will be taken from patients with recurrent Pityriasis Versicolor for the evaluation of vitamin D level.
Interventions
DIAGNOSTIC_TESTHuman 25-Hydroxyvitamin D3 (HVD3) ELISA Kit (96 well)
The serum will be tested by a double-antibody sandwich enzyme-linked immunosorbent assay (ELISA) to assay the level of Human 25Dihydroxy vitamin D（25-OH-D).
Sponsors
Kasr El Aini Hospital
Study design
Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
No
Inclusion criteria
* \- Patients with recurrent pityriasis versicolor (active now) and not taking treatment for it. * Patients of both genders. * Age ≥18 years old.
Exclusion criteria
* \- Patients with other cutaneous diseases. * Patient's having dandruff (scaly scalp) even if not symptomatizing. * Pregnant and lactating females, children, prisoners, cognitively impaired or mentally disabled subjects. * Patients with autoimmune diseases. * Patients with immunodeficiency diseases. * Immunosuppressed patients e.g. HIV, diabetics, organ transplant, malignancy, patients taking immunosuppressive drugs e.g. chemotherapy, cortisone.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Serum 25(OH) D3 level | 6months-1 year | The serum of patients and controls will be tested by a double-antibody sandwich enzyme-linked immunosorbent assay (ELISA) to assay the level of Human 25Dihydroxy vitamin D（25-OH-D). |
Countries
Egypt
Contacts
Primary ContactRana Hilal, M.D
Outcome results
None listed